医学
PCSK9
心脏病学
经皮冠状动脉介入治疗
心肌梗塞
内科学
传统PCI
再灌注损伤
生物标志物
缺血
磁共振成像
放射科
低密度脂蛋白受体
脂蛋白
胆固醇
生物化学
化学
作者
Christina Tiller,Magdalena Holzknecht,Ivan Lechner,F Oberhollenzer,Sebastian von der Emde,Thomas Kremser,Can Gollmann‐Tepeköylü,Agnes Mayr,Axel Bauer,Bernhard Metzler,Sebastian J. Reinstadler,Martin Reindl
标识
DOI：10.1161/circimaging.123.016482
摘要
Beyond therapeutic implications, PCSK9 (proprotein convertase subtilisin/kexin 9) has emerged as a promising cardiovascular biomarker. The exact role of PCSK9 in the setting of acute ST-elevation myocardial infarction (STEMI) is incompletely understood. We aimed to investigate the association of PCSK9 with ischemia-reperfusion injury, visualized by cardiac magnetic resonance imaging, in patients with STEMI revascularized by primary percutaneous coronary intervention (PCI).
科研通智能强力驱动
Strongly Powered by AbleSci AI
cdercder
Rye227
pluto
冰魂
昏睡的蟠桃
bc
jenningseastera
归尘
乐乐
平常的毛豆
back you up
Auston_zhong
不倦
遇上就这样吧
顺心香菇
今天只做一件事
科研小民工
zmnzmnzmn
Cat
wy.he
皖公网安备34019202002308
